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]i) has been implicated in contractile and phenotypic changes in arterial smooth muscle during hypertension. This study examined the role of membrane potential and [Ca 2ϩ ]i in altered gene expression in cerebral arteries of a rat (Dahl) genetic model of salt-sensitive hypertension. Cerebral arteries from hypertensive animals (Dahl salt-sensitive) exhibited a tonic membrane depolarization of ϳ15 mV compared with normotensive (Dahl salt-resistant) animals. Consistent with this membrane depolarization, voltage-dependent K ϩ currents were decreased in cerebral artery myocytes isolated from hypertensive animals. Arterial wall Ca 2ϩ was elevated in cerebral arteries from hypertensive animals, an effect reversed by diltiazem, a blocker of voltage-dependent Ca 2ϩ channels. This depolarization-induced increase in [Ca 2ϩ ]i was associated with increased activation of the transcription factor, cAMP response element binding protein, and increased expression of the immediate early gene c-fos, both of which are reversed by acute exposure to the voltage-dependent Ca 2ϩ channel blocker nisoldipine. This study provides the first information linking altered Ca 2ϩ handling to changes in gene expression in cerebral arteries during hypertension. cerebral arteries; calcium; potassium channels; hypertension INTRACELLULAR CALCIUM ([Ca 2ϩ ] i ) has a central role in the physiology and pathophysiology of arterial smooth muscle by regulating contractility and gene expression. Elevated [Ca 2ϩ ] i has been implicated in both contractile and phenotypic changes of arteries in hypertension (7, 13, 16, 20, 24, 25) . Consistent with elevated [Ca 2ϩ ] i , L-type voltage-dependent Ca 2ϩ channel (VDCC) currents have been reported to be enhanced in vascular smooth muscle during hypertension through both upregulation of the channel itself (29) and through membrane potential depolarization (10) . An alteration in the membrane potential of the vascular smooth muscle during hypertension may reflect changes in the permeability of K ϩ in these cells. Decreased expression of voltage-dependent K ϩ (K v ) channels has been reported in renal arteries from hypertensive rats (16) and in pulmonary arteries from humans with primary pulmonary hypertension (30) . Such a decrease in K v currents would promote membrane potential depolarization. Conversely, Ca 2ϩ -sensitive K ϩ (K Ca ) channel activity is enhanced in vascular smooth muscle from hypertensive animals in an attempt to compensate for the elevation in [Ca 2ϩ ] i (14, 15, 21) . With respect to the cerebral vasculature, the effects of hypertension on K ϩ channel activity or [Ca 2ϩ ] i are poorly understood. Consistent with findings from other vascular beds (7, 16) , the membrane potential of cerebral arteries from spontaneously hypertensive rats has been reported to be more depolarized (9) .
Although functional and structural changes in smooth muscle during hypertension reflect, in part, altered Ca 2ϩ handling and gene expression, the relationship between [ influx to increased c-fos expression via CaM kinasedependent phosphorylation of CREB has previously been identified in hippocampal neurons (1, 5) .
Increased expression of c-fos may also be involved in the cascade of events leading to phenotypic changes in vascular smooth muscle that occur during hyperten-sion. Exposure to hypertrophic and/or proliferative stimuli such as platelet-derived growth factor (PDGF), thrombin, or angiotensin II caused an increase in c-fos levels in cultured aortic (28) and pulmonary arterial smooth muscle cells (24, 27) . In cultured vascular smooth muscle, elevations in [Ca 2ϩ ] i may play an important role in enhanced c-fos expression. Increased c-fos expression has been reported to occur in these cultured myocytes in response to mobilization of Ca 2ϩ from intracellular stores (17, 24, 28) or via Ca 2ϩ influx through dihydropyridine-sensitive L-type VDCCs (13) . However, caution should be exercised in extrapolating studies of cultured vascular smooth muscle (synthetic phenotype) to native vascular smooth muscle (contractile phenotype).
The goal of this study was to examine the role of [Ca 2ϩ ] i in mediating changes in gene expression of cerebral arterial smooth muscle obtained from a rat genetic model of salt-sensitive hypertension. Our results indicate that in hypertension, the membrane potential is depolarized, which likely reflects a decrease in K v current density. [Ca 2ϩ ] i is elevated in hypertension, which appears to result from an elevation of Ca 2ϩ influx through VDCCs. This increase in [Ca 2ϩ ] i leads to an activation of CREB and elevation of gene expression (c-fos).
METHODS
Dahl salt-sensitive (SS, "hypertensive") and Dahl saltresistant (SR, "normotensive") rats 6 wk of age were fed an 8% NaCl diet for 6 wk. Mean arterial blood pressure measurements were taken in these animals using the tail-cuff method. Animals were euthanized by exsanguination while under deep pentobarbital anesthesia (intraperitoneal; 150 mg/kg). Cerebral arteries were dissected in cold (4°C) oxygenated (95% O 2-5% CO2) physiological saline solution (PSS) of the following composition (in mM): 118.5 NaCl, 4.7 KCl, 24 NaHCO3, 1.18 KH2PO4, 2. Membrane potential measurements. Membrane potential measurements were made in arterial myocytes of isolated posterior cerebral artery segments pressurized to 10 mmHg and continuously superfused with oxygenated PSS (37°C). Conventional intracellular microelectrodes filled with 0.5 M KCl were used to impale myocytes from the adventitial surface of arteries. Acceptance of membrane potential recordings was based on previously described criteria (3) . K ϩ current recordings. Smooth muscle cells were enzymatically isolated from cerebral arteries (22) , and whole cell K ϩ currents were measured in these freshly isolated myocytes using the conventional whole cell configuration of the patchclamp technique. Patch pipettes were filled with a solution containing (in mM) 87 potassium aspartate, 20 KCl, 1 CaCl 2, 1 MgCl2, 10 HEPES, 10 EGTA, and 25 KOH (pH 7.2). Free [Ca 2ϩ ] in the pipette solution was calculated to be ϳ100 nM. Recordings were made in an extracellular solution containing (in mM) 134 NaCl, 6 KCl, 1 MgCl2, 0.1 CaCl2, 10 glucose, and 10 HEPES (pH 7.4). To compensate for differences in cell size, membrane K ϩ currents are expressed relative to cell capacitance (pA/pF).
Arterial wall Ca 2ϩ measurements. Cannulated arteries were loaded with the ratiometric Ca 2ϩ -sensitive dye fura-2 acetoxymethyl ester (AM) (2 M) and held at 10 mmHg while continuously superfused with oxygenated PSS (37°C). Arterial [Ca 2ϩ ]i was calculated in fura-2-loaded arteries as described previously (12) .
To examine the effects of membrane depolarization and the role of VDCCs, experiments were also performed using the Ca 2ϩ indicator dye fluo-3. On the basis of arterial wall Ca 2ϩ measurements obtained using fura-2, fractional fluorescence changes in fluo-3-loaded arteries were used to estimate changes in [Ca 2ϩ ]i in response to increased extracellular K ϩ (to 30 mM) or the addition of diltiazem, an organic blocker of VDCCs (18).
Immunofluorescence. Cerebral arteries were treated with test stimuli for 30 min at 37°C. When indicated, isolated arteries were incubated in 100 nM nisoldipine for 15 min before incubation with 60 mM K ϩ , then flash-frozen, and embedded. Arterial cross sections (10 m thick) were fixed and treated with primary antibody [rabbit anti-phosphorylated (P-CREB), 1:250 dilution in 0.2% Triton-X/2% bovine serum albumin-phosphate-buffered saline, New England Biolabs; Beverly, MA] followed by secondary antibody (Cy3 or Cy5-anti-rabbit IgG, 1:500 dilution in 2% bovine serum albumin-phosphate-buffered saline) (4, 26) . Control experiments using either primary antibody only or secondary antibody only (on different slices) revealed virtually no nonspecific staining (data not shown). In addition, the phosphopeptide (1 mg/ml) used to generate the anti-P-CREB antibody was obtained from Cell Signaling Technology (Beverly, MA). No positive P-CREB staining was evident in arteries stimulated with high K ϩ (n ϭ 3 artery sections from each of 3 animals, data not shown) when the anti-P-CREB antibody was incubated for 2 h with the phospho-peptide (1:250 dilution) before staining. Sections were also stained with the cyanine dye YOYO-1 (1:5,000 in PBS) to identify nuclei. Arterial sections contained between 20 and 50 nuclei, and 6 sections per treatment were analyzed for each animal using standardized conditions within Adobe Photoshop.
RNA isolation and RT-PCR. Arteries were treated in a manner similar to that described for immunofluorescence. Total RNA was extracted using TRIzol reagent and quantified using a spectrophotometer. First-strand cDNA was synthesized using Superscript II RNase H-Reverse Transcriptase. To perform RT-PCR, cDNA was amplified using the following sets of primers: c-fos (GenBank Accession no. X06769) sense, nucleotides 1131-1152, and antisense 1426-1446; GAPDH (GenBank Accession no. M17701) sense nucleotides 586-606, and antisense 1017-1037. RT-PCR was performed under the following conditions: 94°C, 1 min; 55°C, 1 min; and 72°C, 2 min for 35 cycles, followed by an incubation at 72°C for 10 min. Experiments have confirmed that the number of PCR cycles (35) used in our study is within the linear amplification range of this assay (n ϭ 3, data not shown). For each animal, reactions with c-fos and GAPDH primers were run next to each other in the thermal cycler and thus exposed to the same PCR cycle. To also reduce variability between tubes, a PCR master mix was prepared containing cDNA, 10 mM deoxynucleotide triphosphates (2.5 mM each), 10 l of 5ϫ PCR buffer (containing 7.5 mM MgCl2, pH 8.5), and 5 units of Taq Polymerase (5 U/l) per reaction. Sense and antisense primers (0.25 g each) were then added to the individual reaction tubes. The final concentration of each reaction was adjusted to 50 l using sterile water. PCR products were separated by agarose gel electrophoresis and quantified using Adobe Photoshop Software. Equal amounts of cDNA were loaded on the gel, and c-fos DNA concentration was normalized to GAPDH expression. All results are expressed as means Ϯ SE.
RESULTS
Cerebral arteries from hypertensive rats are depolarized compared with normotensive animals. Mean arterial pressure was elevated to 183.7 Ϯ 2.7 mmHg (n ϭ 21) in Dahl SS rats, whereas Dahl SR rats remained normotensive (112.4 Ϯ 3.1 mmHg, n ϭ 12) following a period of 6 wk on high-salt (containing 8% NaCl) diet.
To investigate whether this model of hypertension is associated with altered electrical properties of arterial myocytes within the cerebral vasculature, intracellular microelectrodes were used to measure the membrane potential of smooth muscle cells in intact isolated cerebral arteries. As illustrated in Fig. 1A and summarized in Fig. 1B , the membrane potential of cerebral artery myocytes from hypertensive rats (Ϫ36.
animals).
Voltage-dependent K ϩ channel current density is decreased in smooth muscle cells from cerebral arteries of hypertensive rats. The observed membrane depolarization of cerebral arterial smooth muscle from hypertensive animals could reflect either enhanced depolarizing stimuli, decreased hyperpolarizing stimuli, or both. To determine whether K ϩ channel currents were altered in cerebral arteries of hypertensive animals, outward K ϩ currents were directly measured in isolated myocytes using the patch-clamp technique. Mean series resistance was 11.0 Ϯ 1.4 M⍀ (n ϭ 21) and 8.5 Ϯ 0.6 M⍀ (n ϭ 21) in cells from normotensive and hypertensive animals, respectively. Cell capacitance was 15.5 Ϯ 0.6 pF (n ϭ 21) in cells from normotensive and 9.2 Ϯ 0.4 pF (n ϭ 21) in cells from hypertensive animals. Membrane K ϩ currents (in 6 mM external K ϩ ) were elicited by a series of 10-mV depolarizing steps (Ϫ60 to ϩ50 mV) from a holding potential of Ϫ70 mV (Fig. 2A) . Steady-state outward current was significantly less in cerebral artery myocytes isolated from hypertensive animals (15.2 Ϯ 1.7 pA/pF at ϩ50 mV, n ϭ 21) compared with similar cells from normotensive animals (34.8 Ϯ 5.6 pA/pF at ϩ50 mV, n ϭ 21, P Ͻ 0.01, Fig.  2B ). Peak outward currents (i.e., the maximum level of current during a given voltage step) were also significantly less in cerebral arteries from hypertensive (23.2 Ϯ 3.0 pA/pF at ϩ 50 mV, n ϭ 21) compared with cells from normotensive rats (39.9 Ϯ 6.2 pA/pF at ϩ 50 mV, n ϭ 21, P Ͻ 0.05). To determine the nature of the outward currents in these cells, membrane currents were also measured in the presence of iberiotoxin (IBTX, 100 nM, a selective inhibitor K Ca channels), and IBTX plus 4-aminopyridine (4-AP, 10 mM, an inhibitor of some types of K v channels) (Fig. 3A) . IBTX-sensitive currents were not significantly different in cerebral artery myocytes from normotensive compared with hypertensive animals (Fig. 3B) . However, in the presence Fig. 1 . Cerebral arteries from hypertensive rats are depolarized compared with normotensive animals. A: conventional intracellular microelectrode recordings of membrane potential measurements in myocytes of intact cerebral artery segments from normotensive (left) and hypertensive (right) rats. B: summary of the membrane potential of myocytes from normotensive (n ϭ 12 cells from 3 animals) and hypertensive (n ϭ 16 cells from 4 animals) cerebral arteries. *P Ͻ 0.01 of IBTX, both the 4-AP-sensitive and -insensitive currents were significantly less in cells isolated from hypertensive animals at depolarized membrane potentials (Fig. 3, C and D) . These data are consistent with the idea that decreased K v channel conductance leads to the depolarized membrane potential observed in cerebral arteries of hypertensive rats.
Elevation of arterial wall Ca 2ϩ in cerebral arteries of hypertensive rats. The membrane potential depolarization observed in cerebral arteries from hypertensive animals should lead to an elevation of [Ca 2ϩ ] i in the smooth muscle within the arterial wall due to increased Ca 2ϩ influx through VDCCs (12) . In arteries from normotensive animals, arterial wall Ca 2ϩ was 134.9 Ϯ 15.7 nM (n ϭ 4), which is similar to measurements of arterial wall Ca 2ϩ obtained from other strains of normotensive rats under similar conditions (12) . However, in cerebral arteries from hypertensive rats, arterial wall Ca 2ϩ was elevated to 224.4 Ϯ 37.9 nM (n ϭ 5). The organic inhibitor of VDCCs, diltiazem (50 M), reduced [Ca 2ϩ ] i in cerebral arteries from hypertensive and normotensive animals to similar levels (118.6 Ϯ 16.8 nM, n ϭ 4 and 111.2 Ϯ 9.8 nM, n ϭ 6, respectively), indicating that the increase in arterial wall Ca 2ϩ in arteries from hypertensive animals was due to enhanced Ca 2ϩ entry. Furthermore, membrane potential depolarization, by elevating extracellular K ϩ from 6 to 30 mM, increased [Ca 2ϩ ] i approximately 1.6-fold in cerebral arteries from normotensive animals to similar [Ca 2ϩ ] i levels observed in hypertensive arteries under resting (6 mM extracellular K ϩ ) conditions.
Activation of the transcription factor CREB in hypertensive cerebral arteries. An elevation of [Ca 2ϩ ] i by membrane potential depolarization has recently been shown to activate the transcripton factor CREB, by increasing the levels of P-CREB (4). Because smooth muscle cells in hypertensive cerebral arteries are depolarized and exhibit elevated levels of [Ca 2ϩ ] i , we hypothesized that levels of P-CREB should also be increased in cerebral arteries from hypertensive rats. Cross sections of cerebral arteries (10 m thick) were analyzed for P-CREB by immunostaining with an antibody specific for CREB phosphorylated on Ser 133 . Sections were also stained with the cyanine dye YOYO-1 to identify nuclei. Cerebral arteries from hypertensive rats exhibited a significant increase in the number of nuclei staining positive for P-CREB (Fig. 4) .
Treatment of cerebral arteries from hypertensive rats with nisoldipine (100 nM), to block Ca 2ϩ entry through VDCCs, significantly decreased the levels of P-CREB-positive nuclei in arteries from hypertensive rats to a level similar to that observed in cerebral arteries from normotensive rats under resting conditions (6 mM K ϩ ). An increase in P-CREB levels similar to that observed in cerebral arteries during hypertension also occurred in cerebral arteries of normotensive animals following membrane potential depolarization by elevating extracellular K ϩ (Fig. 4) . Whereas nisoldipine (100 nM) had little effect on P-CREB levels in control arteries from normotensive rats, this Ca 2ϩ channel blocker did abolish the increase of P-CREBpositive nuclei caused by membrane depolarization (Fig. 4) . Unlike arteries from normotensive animals, elevation of external K ϩ from 6 to 30 mM or 60 mM K ϩ did not significantly increase levels of P-CREB staining in cerebral arteries from hypertensive rats (Fig. 4) . However, pretreatment of the arteries with nisoldipine was still effective in decreasing the percentage of P-CREB-positive nuclei in cerebral arteries from hypertensive animals in the presence of 60 mM K ϩ . These results indicate that an increase in the phosphorylation of the transcription factor CREB to its active form (P-CREB) in rat cerebral arteries during hypertension is likely a result of membrane potential depolarization and an elevation of [Ca 2ϩ ] i caused by the activation of VDCCs.
Ca 2ϩ -dependent increase in c-fos expression in hypertensive cerebral arteries. Activation of CREB by [Ca 2ϩ ] i in mouse cerebral arteries is associated with an increase in expression of the immediate early gene c-fos (4) . To examine whether the increased phosphorylation of CREB during hypertension also correlates with increased c-fos expression, RT-PCR was performed on RNA extracted from intact cerebral arteries from normotensive and hypertensive rats (Fig. 5) . Treatment with the Ca 2ϩ channel blocker nisoldipine (100 nM) significantly reduced the c-fos-to-GAPDH ratio in cerebral arteries from hypertensive, but not normotensive, arteries. Whereas membrane depolarization with 60 ϩ currents in cerebral artery myocytes isolated from normotensive (n ϭ 6) and hypertensive animals (n ϭ 6). B-D: current density of IBTX-sensitive (B), 4-AP-sensitive (C), and IBTX-and 4-AP-insensitive (D) currents in cerebral artery myocytes isolated from normotensive (n ϭ 6) and hypertensive (n ϭ 6) animals. *P Ͻ 0.05. mM KCl increased the c-fos-to-GAPDH ratio sevenfold in arteries from normotensive animals, this maneuver did not increase c-fos expression in arteries from hypertensive animals. Although RT-PCR measurements performed in this study are qualitative in nature, these results suggest that Ca 2ϩ influx through VDCC leads to increased expression of c-fos in cerebral arteries from hypertensive rats.
DISCUSSION
Hypertension is a complex disease that can arise from a multitude of underlying genetic and environmental factors. Many, if not all, forms of hypertension result in a number of direct effects on the vasculature that include increased contractility, vascular smooth muscle proliferation, and remodeling of the arterial wall. An increase in [Ca 2ϩ ] i in vascular smooth muscle could play an important role in many of these pathological changes. To this extent, we have investigated whether [Ca 2ϩ ] i is altered in cerebral arteries during hypertension using a genetic rat model of salt-sensitive hypertension. We report that in the Dahl model of salt-sensitive hypertension, [Ca 2ϩ ] i is elevated in the smooth muscle of cerebral arteries due to membrane Fig. 4 . Elevated levels of phosphorylated cAMP response element binding protein (P-CREB) in cerebral arteries from hypertensive rats are reversed by the voltage-dependent Ca 2ϩ channel (VDCC) inhibitor nisoldipine (Nis). Arterial cross sections were stained with anti-P-CREB antibody and the nuclear dye YOYO-1. Immunofluorescent images of cerebral arteries from normotensive rats (A) and hypertensive rats (B) are shown. C: summary of effects of membrane depolarization and nisoldipine on levels of P-CREB. Arterial cross sections were evaluated for the percentage of cells staining positive for nuclear P-CREB (n ϭ 3 arteries, 6 sections per artery). PSS, physiological saline solution. *P Ͻ 0.05, Student-Newman-Keuls. Fig. 5 . Effects of membrane depolarization and VDCC inhibition on c-fos levels in cerebral arteries from normotensive and hypertensive rats. RT-PCR was performed on RNA extracted from intact cerebral arteries from normotensive (A) and hypertensive (B) rats. Quantitation of c-fos mRNA levels is expressed relative to GAPDH mRNA, as determined by pixel intensity of scanned gels (n ϭ 3 animals for each group). *P Ͻ 0.01, Student-Newman-Keuls.
potential depolarization, likely reflecting a decrease in K v channel conductance. Furthermore, we provide evidence that this depolarization-induced increase in [Ca 2ϩ ] i is due to increased Ca 2ϩ entry through VDCCs and leads to enhanced activation of the transcription factor CREB and increased expression of the immediate early gene c-fos. This study provides the first information linking altered Ca 2ϩ handling to changes in gene expression in cerebral arteries during hypertension.
Membrane depolarization and elevated [Ca 2ϩ ] i in cerebral artery myocytes with hypertension: role of K v channels. In cerebral arterial smooth muscle, [Ca 2ϩ ] i is regulated by Ca 2ϩ influx through VDCCs (12, 19) . The activity of K ϩ channels is a key determinant of the membrane potential of cerebral vascular smooth muscle. At least two types of K ϩ channels, voltage-dependent (K v , or delayed rectifier), and large-conductance Ca 2ϩ -activated K ϩ channels play a key negative-feedback role to limit Ca 2ϩ entry and pressure-induced constrictions in the cerebral vasculature (2, 6, 11, 18) . We have found the K v channel current density was markedly suppressed in cerebral artery myocytes from hypertensive rats. Our findings are also consistent with reports from other investigators describing decreased K v currents in other rat models of hypertension (16) and human patients with primary pulmonary hypertension (30) . It is also interesting to note that parathyroid hypertensive factor, a substance correlated with low renin, salt-sensitive hypertension in humans, also inhibits K v currents in cultured vascular smooth muscle cells (23) . The mechanism underlying the decrease in K v channel activity remains to be elucidated.
Activation of CREB and c-fos expression in hypertension. We found that the levels of P-CREB-positive nuclei and c-fos expression were elevated in cerebral arteries from hypertensive rats. Membrane potential depolarization of normotensive arteries mimicked the effects of hypertension. In both cases, inhibition of VDCCs decreased the levels of P-CREB and c-fos. These results are consistent with our measurements indicating that smooth muscle cells of cerebral arteries from hypertensive animals exhibit a more depolarized membrane potential and elevated [Ca 2ϩ ] i due to increased Ca 2ϩ influx through VDCCs. Unlike arteries from normotensive animals, elevating external K ϩ from 6 to 60 mM did not significantly increase levels of P-CREB or c-fos in cerebral arteries from hypertensive animals. A likely explanation for the inability of elevated K ϩ to increase P-CREB levels or c-fos expression in hypertensive arteries is that the membrane potential of these arteries under resting conditions (low pressure, 6 mM external K ϩ ) is near the equilibrium potential for K ϩ (E K ) predicted for 30 mM external K ϩ (E K Ϸ Ϫ40 mV) or 60 mM external K ϩ (E K Ϸ Ϫ22 mV). The relationship between membrane potential (or [Ca 2ϩ ] i ) and activation of the transcription factor CREB in arterial smooth muscle appears relatively steep in arteries from normotensive animals, because elevating extracellular K ϩ from 6 mM to either 30 or 60 mM caused a similar increase in the phosphorylation of CREB to its activated form (P-CREB). As a cautionary note, the experiments described in the present study were performed on myocytes from either unpressurized cerebral arteries (P-CREB, c-fos, and patch-clamp studies) or arteries subjected to very low (10 mmHg) intravascular pressure (membrane potential and arterial wall Ca 2ϩ measurements). Future studies are necessary to define the relationship between Ca 2ϩ -dependent gene expression and intravascular pressure with respect to hypertension.
The events downstream from the Ca 2ϩ -dependent increase in the expression of the immediate-early gene c-fos in arterial smooth muscle are unknown. Although VDCC blockers lowered P-CREB levels and c-fos expression in cerebral arteries from hypertensive animals, it is unclear whether downstream events are also influenced. In a variety of biological systems, c-fos acts as a transcription factor to enhance the expression of additional (late response) genes. For example, in neurons, a Ca 2ϩ -dependent increase in c-fos expression is believed to play a critical role in events leading to adaptive responses such as long-term potentiation (8) . In cardiac myocytes, hypertrophic factors such as angiotensin II and endothelin I increase c-fos expression and total cell protein synthesis, both of which are inhibited by blockers of VDCCs. Increased c-fos expression has been linked to proliferative changes (27) and cell growth in cultured vascular smooth muscle (13) . Thus, with hypertension, c-fos expression could be linked to a number of cellular responses that occur in vascular smooth muscle, including hypertrophy, proliferation, and adaptive changes such as alterations in ion channel expression.
In conclusion, our results reveal an increase in [Ca 2ϩ ] i in cerebral arterial smooth muscle in an established model of salt-sensitive hypertension. Furthermore, our study suggests that in this model of hypertension, enhanced Ca 2ϩ entry via VDCCs is coupled to altered gene expression in arterial smooth muscle.
